Financial Metrics
2025 · XBRLRevenue
—
Net Profit
€8,992
Total Assets
€75,376
Equity
€47,746
FTEs
0
Regulatory & Corporate Profile
BCE Status
Actifsince 1996
NBB Filing
Exercice 2025 déposéLegal Form
Priv lim liab coVAT Status
Assujetti actifEstablishments2 unité(s)
Governance1 mandataire(s)
Officers & Governance
Patrick Hanlon
Activities & NACEBEL
21100Fabrication de produits pharmaceutiques de base
Secondary Activities (1)